Efficacy and safety of neoadjuvant therapy for HER2-positive early breast cancer: a network meta-analysis

AIMS: Currently, there are many approaches available for neoadjuvant therapy for human epidermal growth factor receptor 2 (HER2)-positive breast cancer that improve therapeutic efficacy but are also controversial. We conducted a two-step Bayesian network meta-analysis (NMA) to compare odds ratios (O...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jie, Yu, Yushuai, Lin, Yuxiang, Kang, Shaohong, Lv, Xinyin, Liu, Yushan, Lin, Jielong, Wang, Jun, Song, Chuangui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020239/
https://www.ncbi.nlm.nih.gov/pubmed/33868462
http://dx.doi.org/10.1177/17588359211006948

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020239/
https://www.ncbi.nlm.nih.gov/pubmed/33868462
http://dx.doi.org/10.1177/17588359211006948

Ejemplares similares